4//SEC Filing
Olson Eric R 4
Accession 0001209191-22-010710
CIK 0001556263other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:08 PM ET
Size
10.3 KB
Accession
0001209191-22-010710
Insider Transaction Report
Form 4
Olson Eric R
Chief Scientific Officer
Transactions
- Award
Restricted Stock Units
2022-02-15+200,000→ 200,000 total→ Common Stock (200,000 underlying) - Award
Stock Option (right to buy)
2022-02-15+100,000→ 100,000 totalExercise: $1.59Exp: 2032-02-14→ Common Stock (100,000 underlying) - Award
Restricted Stock Units
2022-02-15+80,000→ 80,000 total→ Common Stock (80,000 underlying)
Footnotes (4)
- [F1]This option becomes exercisable as to one quarter (1/4th) of the shares on February 28, 2023, with the remainder vesting in monthly installments equal to one forty-eighth (1/48th) of the original number of shares at the end of each of the next thirty-six (36) months thereafter.
- [F2]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock.
- [F3]These RSUs will vest in four equal annual installments commencing on March 31, 2023.
- [F4]These RSUs will vest in full on March 31, 2025.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001678149
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:08 PM ET
- Size
- 10.3 KB